R4M-16672-45353
2 vaccinations
3 coded responses
19 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 201 / VA
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Moderna
- 2021-01-04
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-13
- 2021-01-18
-
2021-01-18
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-01-25
- 2021-02-01
-
2021-02-03
Dose 2 — Moderna
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-02-05
- 2021-02-06
- 2021-02-07
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-12
- 2021-02-17
- 2021-02-24
-
2021-03-03
Survey response — day 28, dose 2MedDRA: Autoimmune disorder, Immune system disorder — Feeling: GoodFree text: Low immunityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — day 42, dose 2MedDRA: Headache, Immune system disorder — Feeling: PoorFree text: Low immunity and headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-02-03
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Got covid againMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-02-03 | Moderna |
Call center
1 call center case
1 successful
Free text
Release 5 — day 28, dose 2
Symptoms: Low immunity
Release 5 — day 42, dose 2
Symptoms: Low immunity and headaches
Release 11 — 12 months, dose 2
Symptoms: Got covid again
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Autoimmune disorder | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Immune system disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release